Week In Review: VectorBuilder Raises $57 Million For Gene Therapy Delivery CDMO
Chicago-based VectorBuilder, a gene therapy delivery CDMO, raised $57 million in a Series C round from China investors.
United States Anlong Bio Ascletis Pharma Health Fund Maxinovel Pharmaceuticals Yuexiu Industrial Fund
Source: seekingalpha.com